Latest news
FDA Approves Lupin’s Interchangeable Ranibizumab Biosimilar Ranluspec for Multiple Retinal Diseases - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTLupin shareholders approve ₹18 dividend, Deloitte audit - scanx.tradescanx.trade · Tue, 04 Aug 2026 21:32:07 GMTLupin Shares in Focus After USFDA Approval for Injection - EquitypanditEquitypandit · Mon, 03 Aug 2026 06:43:00 GMTLupin receives USFDA approval for Diazepam injection, targets US$ 77.9 million market - Indian Pharma PostIndian Pharma Post · Sat, 01 Aug 2026 06:24:40 GMTLupin launches generic Sugammadex Injection in the US following FDA approval - Indian Pharma PostIndian Pharma Post · Fri, 31 Jul 2026 14:26:45 GMTLupin announces US FDA approval and launch of Sugammadex injection - Express PharmaExpress Pharma · Fri, 31 Jul 2026 07:02:33 GMTLupin receives USFDA approval for Diazepam Injection USP - Business StandardBusiness Standard · Fri, 31 Jul 2026 07:00:00 GMTLupin gets USFDA approval for Diazepam Injection targeting $77.9 million US market - CNBC TV18CNBC TV18 · Fri, 31 Jul 2026 07:00:00 GMT